Cargando…
Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid β peptides
BACKGROUND: A recent human clinical trial of an Alzheimer's disease (AD) vaccine using amyloid beta (Aβ) 1–42 plus QS-21 adjuvant produced some positive results, but was halted due to meningoencephalitis in some participants. The development of a vaccine with mutant Aβ peptides that avoids the...
Autores principales: | Cao, Chuanhai, Lin, Xiaoyang, Wahi, Monika M, Jackson, Eugene A, Potter, Huntington |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270279/ https://www.ncbi.nlm.nih.gov/pubmed/18282292 http://dx.doi.org/10.1186/1471-2202-9-25 |
Ejemplares similares
-
Apolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade
por: Potter, Huntington, et al.
Publicado: (2012) -
Transgenic Rice Expressing Amyloid β-peptide for Oral Immunization
por: Yoshida, Taiji, et al.
Publicado: (2011) -
Dendritic and Langerhans cells respond to Aβ peptides differently: implication for AD immunotherapy
por: Cheng, Jiang, et al.
Publicado: (2015) -
Alzheimer Aβ Peptide Induces Chromosome Mis-Segregation and Aneuploidy, Including Trisomy 21: Requirement for Tau and APP
por: Granic, Antoneta, et al.
Publicado: (2010) -
The Amyloid Forming Peptides Islet Amyloid Polypeptide and Amyloid β Interact at the Molecular Level
por: Wang, Ye, et al.
Publicado: (2021)